glp-1 news november 5 2025 ISPOR 2025: Exploring reasons for discontinuation Medicare $50 GLP-1 Weight Loss

Machine learning algorithms trained on existing GLP-1 receptor modulators likely helped establish correlations between structural features and functional outcomes, guiding medicinal chemistry efforts toward the most promising compounds

European Journal of Biochemistry, 214, 829835

ERK1-mediated immunomodulation of mesenchymal stem cells ameliorates inflammatory disorders

The company now holds 22 patents with 63 more pending and has raised over $150 million from investors including Meritech Capital Partners, Sequoia Capital, Khosla Ventures, True Ventures, AME Cloud Ventures and the Mayo Clinic

Any change to your treatment schedule should be guided by a healthcare professional